Sangamo Therapeutics
SGMO
#9879
Rank
C$75.61 M
Marketcap
C$0.18
Share price
-5.46%
Change (1 day)
-70.27%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -C$0.16 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are C$32.87 Million. In 2024 the company made an earning of -C$0.14 Billion, an increase over its 2023 earnings that were of -C$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.16 Billion14.03%
2024 -C$0.14 Billion-17.27%
2023 -C$0.17 Billion-40.88%
2022 -C$0.28 Billion9.79%
2021 -C$0.26 Billion41.52%
2020 -C$0.18 Billion23.17%
2019 -C$0.15 Billion36.33%
2018 -C$0.11 Billion36.89%
2017 -C$77.18 Million-22.32%
2016 -C$99.36 Million54.86%
2015 -C$64.17 Million75.62%
2014 -C$36.54 Million0.13%
2013 -C$36.49 Million
2011 -C$49.06 Million43.66%
2010 -C$34.15 Million28.52%
2009 -C$26.57 Million-23.55%
2008 -C$34.76 Million2.45%
2007 -C$33.93 Million19.5%
2006 -C$28.39 Million50.78%
2005 -C$18.83 Million75%
2004 -C$10.76 Million-33.25%
2003 -C$16.12 Million-62.27%
2002 -C$42.72 Million102.82%
2001 -C$21.07 Million23.21%
2000 -C$17.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.57 B-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.44 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.22 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-C$3.47 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.41 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.00 B-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.19 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.52 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA